Correction: Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC).
Lee SY, Cho HJ, Choi J, Ku B, Moon SW, Moon MH, Kim KS, Hyun K, Kim TJ, Sung YE, Hwang Y, Lee E, Ahn DH, Choi JY, Lim JU, Park CK, Kim SW, Kim SJ, Koo IS, Jung WS, Lee SH, Yeo CD, Lee DW.
Lee SY, et al. Among authors: kim sw, kim tj, kim sj, kim ks.
J Exp Clin Cancer Res. 2023 Dec 6;42(1):332. doi: 10.1186/s13046-023-02919-3.
J Exp Clin Cancer Res. 2023.
PMID: 38057916
Free PMC article.
No abstract available.